Tianjin Chase Sun Pharmaceutical Co Ltd Capital Reinvestment Ratio
Tianjin Chase Sun Pharmaceutical Co Ltd capital reinvestment ratio. Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a Capital Reinvestment Ratio of 0.14x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥153.30 Million) in capital expenditures (CN¥21.58 Million). Check 300026 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)
Capital reinvestment ratio of Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2024. This chart tracks Tianjin Chase Sun Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 19 annual periods. Also explore 300026 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Tianjin Chase Sun Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2006–2024)
Tianjin Chase Sun Pharmaceutical Co Ltd capital reinvestment ratio by year from 2006 to 2024. For the full cash flow conversion analysis, see 300026 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.23x | CN¥852.24 Million | CN¥193.12 Million | ▼ -0.1% |
| 2023 | 0.23x | CN¥1.53 Billion | CN¥347.12 Million | ▼ -78.0% |
| 2022 | 1.03x | CN¥745.35 Million | CN¥770.27 Million | ▼ -40.3% |
| 2021 | 1.73x | CN¥391.60 Million | CN¥677.45 Million | ▼ -39.7% |
| 2020 | 2.87x | CN¥196.66 Million | CN¥563.78 Million | ▲ +4.8% |
| 2019 | 2.73x | CN¥216.10 Million | CN¥591.01 Million | ▲ +260.0% |
| 2018 | 0.76x | CN¥388.19 Million | CN¥294.89 Million | ▲ +47.1% |
| 2017 | 0.52x | CN¥742.38 Million | CN¥383.34 Million | ▼ -44.3% |
| 2016 | 0.93x | CN¥448.08 Million | CN¥415.52 Million | ▼ -49.8% |
| 2015 | 1.85x | CN¥121.00 Million | CN¥223.35 Million | ▲ +55.2% |
| 2014 | 1.19x | CN¥149.94 Million | CN¥178.37 Million | ▲ +59.4% |
| 2013 | 0.75x | CN¥143.60 Million | CN¥107.20 Million | ▼ -48.6% |
| 2012 | 1.45x | CN¥152.21 Million | CN¥221.17 Million | ▼ -80.3% |
| 2011 | 7.37x | CN¥35.64 Million | CN¥262.51 Million | ▲ +201.7% |
| 2010 | 2.44x | CN¥46.25 Million | CN¥112.90 Million | ▲ +561.8% |
| 2009 | 0.37x | CN¥135.06 Million | CN¥49.82 Million | ▼ -40.6% |
| 2008 | 0.62x | CN¥77.74 Million | CN¥48.28 Million | ▲ +661.3% |
| 2007 | 0.08x | CN¥72.01 Million | CN¥5.87 Million | ▼ -96.8% |
| 2006 | 2.54x | CN¥1.22 Million | CN¥3.12 Million | — |